Indegene, a digital-first life sciences commercialization company,
announced a new center in Hyderabad to strengthen its global delivery operations and better address growing
business needs.
As the pharma industry faces increasing pressure to innovate and adapt, this new center will play a key role in
helping companies accelerate their transformation. This move aligns with Indegene’s purpose: to enable healthcare
organizations to be future-ready by combining deep medical expertise with fit-for-purpose technology.
India is rapidly emerging as a critical hub for global pharma companies, fueled by its vast pool of skilled medical
and technology talent. These companies are increasingly seeking a partner with core domain expertise and life
sciences-contextualized technology to help them scale their operations in a non-linear, technology-led way.
“Indegene has a strong track record in helping global pharma companies reimagine their commercialization
processes, drive innovation with GenAI, and fully integrate these capabilities into their business processes,” said
Manish Gupta, Chairman and CEO of Indegene. “With the new center, we are further strengthening our capabilities
to help life sciences companies modernize and transform their commercial, medical and clinical operations, with
our fit-for-purpose technology.”
Indegene’s leadership in life sciences commercialization has been further recognized by the Everest Group, which
named the company a Leader in its Life Sciences Digital Services Specialist PEAK Matrix® Assessment 2024.
Additionally, HFS Research recently recognized Indegene as a Leader in GenAI in Life Sciences, further validating
the latter’s ongoing commitment to innovation and excellence in the industry.
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the
world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. This vast global
footprint underscores Indegene’s ability to scale and meet the evolving needs of the world’s leading pharma
organizations across markets.